Correlation Between Inhibikase Therapeutics and Corcept Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Corcept Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Corcept Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Corcept Therapeutics Incorporated, you can compare the effects of market volatilities on Inhibikase Therapeutics and Corcept Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Corcept Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Corcept Therapeutics.
Diversification Opportunities for Inhibikase Therapeutics and Corcept Therapeutics
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inhibikase and Corcept is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Corcept Therapeutics Incorpora in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corcept Therapeutics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Corcept Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corcept Therapeutics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Corcept Therapeutics go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Corcept Therapeutics
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 2.2 times more return on investment than Corcept Therapeutics. However, Inhibikase Therapeutics is 2.2 times more volatile than Corcept Therapeutics Incorporated. It trades about 0.11 of its potential returns per unit of risk. Corcept Therapeutics Incorporated is currently generating about 0.23 per unit of risk. If you would invest 261.00 in Inhibikase Therapeutics on September 3, 2024 and sell it today you would earn a total of 31.00 from holding Inhibikase Therapeutics or generate 11.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Corcept Therapeutics Incorpora
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Corcept Therapeutics |
Inhibikase Therapeutics and Corcept Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Corcept Therapeutics
The main advantage of trading using opposite Inhibikase Therapeutics and Corcept Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Corcept Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corcept Therapeutics will offset losses from the drop in Corcept Therapeutics' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Corcept Therapeutics vs. Ideaya Biosciences | Corcept Therapeutics vs. AnaptysBio | Corcept Therapeutics vs. MeiraGTx Holdings PLC | Corcept Therapeutics vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |